Boston Family Office LLC Novartis Ag Transaction History

Boston Family Office LLC

$1.48 Billion
Q3 2024

A detailed history of Boston Family Office LLC transactions in Novartis Ag stock. As of the latest transaction made, Boston Family Office LLC holds 12,935 shares of NVS stock, worth $1.26 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

12,935

Previous 12,935 -0.0%

Holding current value

$1.26 Million

Previous $1.38 Million 8.06%

% of portfolio

0.1%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $14,290 - $16,270	-150 Reduced 1.15%	12,935 $1.25 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $166,813 - $189,152	-1,803 Reduced 12.11%	13,085 $1.32 Million
Q1 2023 May 10, 2023	BUY	$80.03 - $92.81 $240 - $278	3 Added 0.02%	14,888 $1.37 Million
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $45,330 - $55,512	-600 Reduced 3.87%	14,885 $1.35 Million
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $28,182 - $32,812	-350 Reduced 2.21%	15,485 $1.31 Million
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $44,060 - $49,841	-550 Reduced 3.36%	15,835 $1.39 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $34,271 - $37,895	-430 Reduced 2.56%	16,385 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $43,261 - $50,329	-529 Reduced 3.05%	16,815 $1.38 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $29,834 - $32,952	-350 Reduced 1.98%	17,344 $1.58 Million
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $52,688 - $62,134	-631 Reduced 3.44%	17,694 $1.55 Million
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $13,639 - $19,108	-193 Reduced 1.04%	18,325 $1.51 Million
Q4 2019 Feb 05, 2020	SELL	$84.35 - $95.37 $471,432 - $533,022	-5,589 Reduced 23.18%	18,518 $1.75 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $256 - $282	-3 Reduced 0.01%	24,107 $2.1 Million
Q2 2019 Jul 30, 2019	SELL	$75.4 - $92.8 $7,540 - $9,280	-100 Reduced 0.41%	24,110 $2.2 Million
Q1 2019 May 09, 2019	SELL	$75.32 - $86.15 $16,796 - $19,211	-223 Reduced 0.91%	24,210 $2.33 Million
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $152,107 - $169,371	-2,065 Reduced 7.79%	24,433 $2.1 Million
Q2 2018 Jul 26, 2018	SELL	$64.91 - $73.36 $85,356 - $96,468	-1,315 Reduced 4.73%	26,498 $2 Million
Q1 2018 Apr 30, 2018	SELL	$70.39 - $84.15 $61,943 - $74,052	-880 Reduced 3.07%	27,813 $2.25 Million
Q4 2017 Feb 06, 2018	SELL	$72.33 - $77.64 $31,101 - $33,385	-430 Reduced 1.48%	28,693 $2.41 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $2.16 Million - $2.25 Million	29,123	29,123 $2.5 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Account

Boston Family Office LLC Novartis Ag Transaction History